prednisone has been researched along with HIV in 19 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Excerpt | Relevance | Reference |
---|---|---|
"To examine the effect of 2 weeks of treatment with prednisone on the incidence of nevirapine-associated rash in HIV-1-infected patients receiving combination antiretroviral therapy." | 9.10 | Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1. ( Cahn, P; Casssetti, LI; Gigliotti, M; Hall, DB; Losso, M; McDonough, M; Montaner, JS; Robinson, PA; Wruck, J; Zala, C, 2003) |
"This is a phase 2 study to assess the role of tumor histogenesis (subtype), fluorodeoxyglucose positron emission tomography (FDG-PET), and short-course etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin with dose-dense rituximab (SC-EPOCH-RR) in newly diagnosed HIV-associated CD20(+) diffuse large B-cell lymphoma." | 5.14 | The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. ( Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R, 2010) |
"To examine the effect of 2 weeks of treatment with prednisone on the incidence of nevirapine-associated rash in HIV-1-infected patients receiving combination antiretroviral therapy." | 5.10 | Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1. ( Cahn, P; Casssetti, LI; Gigliotti, M; Hall, DB; Losso, M; McDonough, M; Montaner, JS; Robinson, PA; Wruck, J; Zala, C, 2003) |
" Our study aimed to investigate the prognosis and compare outcome of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab (DA-EPOCH-R) with standard cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab(R-CHOP) as front line therapy for PLHIV with diffuse large B-cell lymphoma (DLBCL) receiving modern combined antiretroviral therapy (cART)." | 3.96 | Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China. ( Chen, J; Liu, L; Qi, TK; Shen, YZ; Song, W; Sun, JJ; Tang, Y; Wang, JR; Wang, ZY; Zhang, RF, 2020) |
"Limited comparative data exist for the treatment of HIV-associated non-Hodgkin lymphoma." | 2.49 | Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. ( Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
Authors | Studies |
---|---|
Rapiti, N | 1 |
Abdelatif, N | 1 |
Rapiti, A | 1 |
Moosa, MY | 1 |
Sun, JJ | 1 |
Liu, L | 1 |
Wang, JR | 1 |
Shen, YZ | 1 |
Qi, TK | 1 |
Wang, ZY | 1 |
Tang, Y | 1 |
Song, W | 1 |
Chen, J | 1 |
Zhang, RF | 1 |
Ke, YL | 1 |
Hsiao, HH | 1 |
Cho, SF | 1 |
Wu, CC | 1 |
Harrison, MJ | 1 |
Brice, N | 1 |
Scott, C | 1 |
Barta, SK | 1 |
Xue, X | 1 |
Wang, D | 1 |
Tamari, R | 1 |
Lee, JY | 2 |
Mounier, N | 1 |
Kaplan, LD | 2 |
Ribera, JM | 1 |
Spina, M | 2 |
Tirelli, U | 2 |
Weiss, R | 1 |
Galicier, L | 1 |
Boue, F | 1 |
Wilson, WH | 2 |
Wyen, C | 1 |
Oriol, A | 1 |
Navarro, JT | 1 |
Dunleavy, K | 2 |
Little, RF | 2 |
Ratner, L | 2 |
Garcia, O | 1 |
Morgades, M | 1 |
Remick, SC | 2 |
Noy, A | 2 |
Sparano, JA | 2 |
Koizumi, Y | 1 |
Uehira, T | 1 |
Ota, Y | 1 |
Ogawa, Y | 1 |
Yajima, K | 1 |
Tanuma, J | 1 |
Yotsumoto, M | 1 |
Hagiwara, S | 1 |
Ikegaya, S | 1 |
Watanabe, D | 1 |
Minamiguchi, H | 1 |
Hodohara, K | 1 |
Murotani, K | 1 |
Mikamo, H | 1 |
Wada, H | 1 |
Ajisawa, A | 1 |
Shirasaka, T | 1 |
Nagai, H | 1 |
Kodama, Y | 1 |
Hishima, T | 1 |
Mochizuki, M | 1 |
Katano, H | 1 |
Okada, S | 1 |
Andhavarapu, S | 1 |
Tolentino, AM | 1 |
Jha, C | 1 |
Ravi, J | 1 |
Carlson, R | 1 |
Nair, GR | 1 |
Levine, AM | 1 |
Ramos, JC | 1 |
Ambinder, RF | 1 |
Wachsman, W | 1 |
Aboulafia, D | 1 |
Henry, DH | 1 |
Von Roenn, J | 1 |
Dezube, BJ | 1 |
Shah, MH | 1 |
Leichman, L | 1 |
Cesarman, E | 1 |
Chadburn, A | 1 |
Mitsuyasu, R | 1 |
Pittaluga, S | 1 |
Grant, N | 1 |
Wayne, AS | 1 |
Carrasquillo, JA | 1 |
Steinberg, SM | 1 |
Yarchoan, R | 1 |
Jaffe, ES | 1 |
Mihaljevic, BS | 1 |
Todorovic, MR | 1 |
Andjelic, BM | 1 |
Antic, DA | 1 |
Perunicic Jovanovic, MD | 1 |
Montaner, JS | 1 |
Cahn, P | 1 |
Zala, C | 1 |
Casssetti, LI | 1 |
Losso, M | 1 |
Hall, DB | 1 |
Wruck, J | 1 |
McDonough, M | 1 |
Gigliotti, M | 1 |
Robinson, PA | 1 |
Tavel, JA | 1 |
Sereti, I | 1 |
Walker, RE | 1 |
Hahn, B | 1 |
Kovacs, JA | 1 |
Jagannatha, S | 1 |
Davey, RT | 1 |
Falloon, J | 1 |
Polis, MA | 1 |
Masur, H | 1 |
Metcalf, JA | 1 |
Stevens, R | 1 |
Rupert, A | 1 |
Baseler, M | 1 |
Lane, HC | 1 |
Youngster, I | 1 |
Vaisben, E | 1 |
Cohen, H | 1 |
Nassar, F | 1 |
Rossi, G | 1 |
Donisi, A | 1 |
Casari, S | 1 |
Re, A | 1 |
Stellini, R | 1 |
Cadeo, G | 1 |
Carosi, G | 1 |
Gabarre, J | 1 |
Fasan, M | 1 |
Vaccher, E | 1 |
Cornfield, DB | 1 |
Papiez, JS | 1 |
Lynch, JT | 1 |
Rimsza, LM | 1 |
Miller, RG | 1 |
Laurence, J | 1 |
Sellers, MB | 1 |
Sikder, SK | 1 |
Kerman, RH | 1 |
Flechner, SM | 1 |
Van Buren, CT | 1 |
Lorber, MI | 1 |
Dawson, G | 1 |
Falk, L | 1 |
Gutierrez, R | 1 |
Hollinger, JB | 1 |
Kahan, BD | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Phase II Trial of EPOCH Given Either Concurrently or Sequentially With Rituximab in Patients With Intermediate- or High-Grade HIV-Associated B-cell Non-Hodgkin's Lymphoma[NCT00049036] | Phase 2 | 106 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma[NCT00001563] | Phase 2 | 39 participants (Actual) | Interventional | 1997-01-08 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Complete response defined by the International Response Criteria for Non-Hodgkin's Lymphoma (NCT00049036)
Timeframe: 60 days
Intervention | proportion (Number) |
---|---|
EPOCH + Concurrent Rituximab | 0.69 |
EPOCH Followed by Rituximab | 0.53 |
4 reviews available for prednisone and HIV
Article | Year |
---|---|
Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2022 |
Clinical Features of HIV Arthropathy in Children: A Case Series and Literature Review.
Topics: Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; CD4 Lymph | 2021 |
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combi | 2013 |
Neuropathies and myopathies complicating HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Action Potentials; Adult; Antiviral Agents; Azathioprine; Combin | 1991 |
6 trials available for prednisone and HIV
Article | Year |
---|---|
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine | 2010 |
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Ag | 2010 |
Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1.
Topics: CD4 Lymphocyte Count; Drug Administration Schedule; Exanthema; Female; HIV; HIV Infections; Humans; | 2003 |
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphoc | 2003 |
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; | 1998 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etop | 2000 |
9 other studies available for prednisone and HIV
Article | Year |
---|---|
Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China.
Topics: Antineoplastic Combined Chemotherapy Protocols; China; Cyclophosphamide; Doxorubicin; HIV; HIV Infec | 2020 |
A tip of the iceberg: Disseminated plasmablastic lymphoma, diagnosed from a local oral lesion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy | 2021 |
Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; | 2016 |
Diffuse large B-cell lymphoma presenting as multiple lymphomatous polyposis of the gastrointestinal tract.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2008 |
Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; HIV; HIV Infections; | 2012 |
An unusual cause of pleural effusion.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Diff | 2006 |
Natural killer-like T-cell lymphoma of the parotid in a patient infected with human immunodeficiency virus.
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophospha | 2002 |
Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription.
Topics: Acquired Immunodeficiency Syndrome; Cell Division; Cell Line; Dexamethasone; Gene Expression Regulat | 1989 |
Investigation of HTLV-3 serology in a renal transplant population.
Topics: Antibodies, Viral; Azathioprine; Blood Transfusion; Cyclosporins; Histocompatibility Testing; HIV; H | 1987 |